• Je něco špatně v tomto záznamu ?

Promoter methylation of GATA4, WIF1, NTRK1 and other selected tumour suppressor genes in ovarian cancer

M. Chmelařová, E. Dvořáková, J. Špaček, J. Laco, M. Mžik, V. Palička

. 2013 ; 59 (2) : 87-92.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14046047

Ovarian cancer is the leading cause of death from gynaecologic tumours, but the molecular and especially epigenetic events underlying the transformation are poorly understood. Various methylation changes have been identified and show promise as potential cancer biomarkers. The aim of this study was to investigate promoter methylation of selected tumour suppressor genes in ovarian cancer by comparison with normal ovarian tissue. To search for epigenetic events we used methylation-specific multiplex ligation-dependent probe amplification to compare the methylation status of 44 tissue samples of ovarian cancer with 30 control samples. Using a 20% cut-off for methylation, we observed significantly higher methylation in genes NTKR1, GATA4 and WIF1 in the ovarian cancer group compared with the control group. These findings could potentially be used in screening of ovarian cancer, and may have implications for future chemotherapy based on epigenetic changes.

000      
00000naa a2200000 a 4500
001      
bmc14046047
003      
CZ-PrNML
005      
20140221091142.0
007      
ta
008      
140212s2013 xr d f 000 0|eng||
009      
AR
035    __
$a (PubMed)23746174
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Chmelařová, Marcela $7 xx0191598 $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic
245    10
$a Promoter methylation of GATA4, WIF1, NTRK1 and other selected tumour suppressor genes in ovarian cancer / $c M. Chmelařová, E. Dvořáková, J. Špaček, J. Laco, M. Mžik, V. Palička
520    9_
$a Ovarian cancer is the leading cause of death from gynaecologic tumours, but the molecular and especially epigenetic events underlying the transformation are poorly understood. Various methylation changes have been identified and show promise as potential cancer biomarkers. The aim of this study was to investigate promoter methylation of selected tumour suppressor genes in ovarian cancer by comparison with normal ovarian tissue. To search for epigenetic events we used methylation-specific multiplex ligation-dependent probe amplification to compare the methylation status of 44 tissue samples of ovarian cancer with 30 control samples. Using a 20% cut-off for methylation, we observed significantly higher methylation in genes NTKR1, GATA4 and WIF1 in the ovarian cancer group compared with the control group. These findings could potentially be used in screening of ovarian cancer, and may have implications for future chemotherapy based on epigenetic changes.
650    _2
$a adaptorové proteiny signální transdukční $x genetika $x metabolismus $7 D048868
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a metylace DNA $x genetika $7 D019175
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a transkripční faktor GATA4 $x genetika $x metabolismus $7 D050991
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory vaječníků $x genetika $x patologie $7 D010051
650    12
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a receptor trkA $x genetika $x metabolismus $7 D020917
650    _2
$a represorové proteiny $x genetika $x metabolismus $7 D012097
650    _2
$a nádorové supresorové proteiny $x genetika $x metabolismus $7 D025521
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dvořáková, Eva $u Department of Obstetrics and Gyneacology, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic $7 xx0230854
700    1_
$a Špaček, Jiří, $u Department of Obstetrics and Gyneacology, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic $7 xx0143233 $d 1957-
700    1_
$a Laco, Jan, $u The Fingerland Department of Pathology, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic $d 1979- $7 xx0051050
700    1_
$a Mžik, Martin $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic $d 1979-, $7 xx0262461
700    1_
$a Palička, Vladimír, $u Institute for Clinical Biochemistry and Diagnostics, Charles University in Prague – Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic $d 1946- $7 jn99240000830
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 59, č. 2 (2013), s. 87-92
856    41
$u https://fb.cuni.cz/file/5683/FB2013A0010.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y 4 $z 0
990    __
$a 20140212 $b ABA008
991    __
$a 20140221090811 $b ABA008
999    __
$a ok $b bmc $g 1013815 $s 844581
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 59 $c 2 $d 87-92 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK138 $a Pubmed-20140212

Najít záznam

Citační ukazatele

    Možnosti archivace